Chapter 464 Red Blood Cell Transfusions and Erythropoietin Therapy
Red blood cells (RBCs) are transfused to increase the oxygen-carrying capacity of the blood and, in turn, to maintain satisfactory tissue oxygenation. Guidelines for RBC transfusions in children and adolescents are similar to those for adults (see Table 464-1 on the Nelson Textbook of Pediatrics website at www.expertconsult.com). However, transfusions may be given more stringently to children, because normal hemoglobin levels are lower in healthy children than in adults and, often, children do not have the underlying multiorgan, cardiorespiratory, and vascular diseases that develop with aging in adults. Thus, children often compensate better for RBC loss and, as is true for patients of all ages, there is increasing enthusiasm for conservative practices (i.e., low pre-transfusion hematocrit values).
Table 464-1 GUIDELINES FOR PEDIATRIC RED BLOOD CELL TRANSFUSIONS*†
CHILDREN AND ADOLESCENTS
INFANTS ≤ 4 MO OLD
* Words in italics must be defined for local transfusion guidelines.
† Pre-transfusion blood hemoglobin level (or hematocrit estimated by hemoglobin g/dL × 3) prompting a red blood cell transfusion. Values vary among published reports and should be determined locally to fit best with practices judged to be optimal by local MDs.
With chronic anemia, the decision to transfuse RBCs should not be based solely on blood hemoglobin levels, because children compensate well and may be asymptomatic despite low hemoglobin levels. Patients with iron deficiency anemia are often treated successfully with oral iron alone, even at hemoglobin levels < 5 g/dL. Factors other than hemoglobin concentration to be considered in the decision to transfuse RBCs include: (1) the patient’s symptoms, signs, and compensatory capacities; (2) the presence of cardiorespiratory, vascular, and central nervous system disease; (3) the cause and anticipated course of the anemia; and (4) alternative therapies, such as recombinant human erythropoietin (EPO) therapy, which is known to reduce the need for RBC transfusions and to improve the overall condition of children with chronic renal insufficiency (Chapter 529.2